Agios Pharmaceuticals, Inc. (AGIO)
33.13
-1.00
(-2.93%)
USD |
NASDAQ |
Sep 03, 16:00
33.42
+0.29
(+0.88%)
After-Hours: 04:39
Agios Pharmaceuticals Cash and Short Term Investments (Annual) : 854.42M for Dec. 31, 2025
Cash and Short Term Investments (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Cash and Short Term Investments (Annual) Data
| Date | Value |
|---|---|
| December 31, 2025 | 854.42M |
| December 31, 2024 | 893.71M |
| December 31, 2023 | 776.93M |
| December 31, 2022 | 783.12M |
| December 31, 2021 | 1.020B |
| December 31, 2020 | 572.93M |
| December 31, 2019 | 564.88M |
| December 31, 2018 | 585.30M |
| Date | Value |
|---|---|
| December 31, 2017 | 423.94M |
| December 31, 2016 | 541.31M |
| December 31, 2015 | 317.00M |
| December 31, 2014 | 342.06M |
| December 31, 2013 | 166.77M |
| December 31, 2012 | 127.98M |
| December 31, 2011 | 179.17M |
Cash and Short Term Investments Definition
Represents the sum of cash and short term investments.
Cash and Short Term Investments (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash and Short Term Investments (Annual) Benchmarks
| ACADIA Pharmaceuticals, Inc. | 819.69M |
| Biogen, Inc. | 3.816B |
| Insmed, Inc. | 1.430B |
| Alnylam Pharmaceuticals, Inc. | 2.908B |
| Exelixis, Inc. | 1.059B |